Advertisement

Topics

Short seller Kerrisdale targets Woodford-backed Prothena

06:20 EST 8 Nov 2017 | Reuters

LONDON (Reuters) - Hedge fund Kerrisdale Capital has taken a short position in drugmaker Prothena, a company backed by UK investor Neil Woodford, calling it "the next big biotech blowup".

Original Article: Short seller Kerrisdale targets Woodford-backed Prothena

NEXT ARTICLE

More From BioPortfolio on "Short seller Kerrisdale targets Woodford-backed Prothena"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...